Skip Navigation
Skip to contents

Intest Res : Intestinal Research

IMPACT FACTOR

Author index

Page Path
HOME > Browse articles > Author index
Search
Charanpreet Singh Grewal 1 Article
IBD
Efficacy of fecal microbiota therapy in steroid dependent ulcerative colitis: a real world intention-to-treat analysis
Ajit Sood, Ramit Mahajan, Garima Juyal, Vandana Midha, Charanpreet Singh Grewal, Varun Mehta, Arshdeep Singh, Mohan C Joshi, Vikram Narang, Kirandeep Kaur, Hasrat Sidhu
Intest Res 2019;17(1):78-86.   Published online November 20, 2018
DOI: https://doi.org/10.5217/ir.2018.00089
AbstractAbstract PDFSupplementary MaterialPubReaderePub
Background/Aims
Four high-quality randomized controlled trials have proven the efficacy of fecal microbiota transplantation (FMT) in active ulcerative colitis (UC). We assessed the efficacy of FMT in a real-world setting involving steroid-dependent patients with UC.
Methods
This was a single-center prospective analysis of data from steroid-dependent patients with UC treated with FMT from September 2015 to September 2017 at the Dayanand Medical College, a tertiary care center in India. Fecal samples from random unrelated donors were administered through colonoscopy at weeks 0, 2, 6, 10, 14, 18, and 22. The primary outcome was achievement of steroid-free clinical remission, and the secondary outcomes were clinical response and endoscopic remission at 24 weeks. Modified intention-to-treat analysis was performed, which included subjects who underwent at least 1 FMT.
Results
Of 345 patients with UC treated during the study period, 49 (14.2%) had steroid-dependent UC. Of these 49 patients, 41 underwent FMT: 33 completed 7 sessions over 22 weeks according to the protocol, and 8 discontinued treatment (non-response, 5; lost to follow-up, 2; and fear of adverse effects, 1). At week 24, steroid-free clinical remission was achieved in 19 out of 41 (46.3%) patients, whereas clinical response and endoscopic remission were achieved in 31 out of 41 (75.6%) and 26 out of 41 (63.4%) patients, respectively. All patients with clinical response were able to withdraw steroids. There were no serious adverse events necessitating discontinuation.
Conclusions
A multisession FMT via the colonoscopic route is a promising therapeutic option for patients with steroid-dependent UC, as it can induce clinical remission and aid in steroid withdrawal.

Citations

Citations to this article as recorded by  
  • The practice of fecal microbiota transplantation in inflammatory bowel disease
    Umang Arora, Saurabh Kedia, Vineet Ahuja
    Intestinal Research.2024; 22(1): 44.     CrossRef
  • Current perspectives on fecal microbiota transplantation in inflammatory bowel disease
    Arshdeep Singh, Vandana Midha, Nar Singh Chauhan, Ajit Sood
    Indian Journal of Gastroenterology.2024; 43(1): 129.     CrossRef
  • Artemisia argyi polyphenols Attenuates DSS-induced colitis in mice by regulating the structural composition of gut microbiota
    Huaqiang Zhang, Zhonghua Hao, Ruya Zhang, Jiang Tong, Xiaoke Wang, Jingjing Liu, Yingkui Gao, Xuefang Wang, Qing Su, Haojie Wen, Yi Fan, Fang Liu, Xiao Li, Chao Tong, Xuebing Wang
    Phytomedicine.2024; 132: 155897.     CrossRef
  • Perception of fecal microbiota transplantation in patients with ulcerative colitis in Korea: a KASID multicenter study
    Jebyung Park, Sung Noh Hong, Hong Sub Lee, Jongbeom Shin, Eun Hye Oh, Kwangwoo Nam, Gyeol Seong, Hyun Gun Kim, Jin-Oh Kim, Seong Ran Jeon
    The Korean Journal of Internal Medicine.2024; 39(5): 783.     CrossRef
  • Fecal transplantation for treatment of inflammatory bowel disease
    Aamer Imdad, Natasha G Pandit, Muizz Zaman, Nathan Zev Minkoff, Emily E Tanner-Smith, Oscar G Gomez-Duarte, Sari Acra, Maribeth R Nicholson
    Cochrane Database of Systematic Reviews.2023;[Epub]     CrossRef
  • Single-Donor and Pooling Strategies for Fecal Microbiota Transfer Product Preparation in Ulcerative Colitis: Systematic Review and Meta-Analysis
    Benoît Levast, Mathieu Fontaine, Stéphane Nancey, Pierre Dechelotte, Joël Doré, Philippe Lehert
    Clinical and Translational Gastroenterology.2023;[Epub]     CrossRef
  • Lithium carbonate alleviates colon inflammation through modulating gut microbiota and Treg cells in a GPR43-dependent manner
    Shengjie Huang, Shiping Hu, Shuang Liu, Bo Tang, Yaojiang Liu, Li Tang, Yuanyuan Lei, Li Zhong, Shiming Yang, Song He
    Pharmacological Research.2022; 175: 105992.     CrossRef
  • Gut microbiota in inflammatory bowel disease: a target for therapy not to be missed
    Tiziana LARUSSA, Ludovico ABENAVOLI, Giulia FABIANO, Maria A. MANCUSO, Natale POLIMENI, Dan L. DUMITRASCU, Francesco LUZZA
    Minerva Gastroenterology.2022;[Epub]     CrossRef
  • Fecal microbiota transplantation for induction of remission, maintenance and rescue in patients with corticosteroid-dependent ulcerative colitis: a long-term follow-up real-world cohort study
    Avnish Kumar Seth, Priti Jain
    Intestinal Research.2022; 20(2): 251.     CrossRef
  • Systematic review of donor and recipient predictive biomarkers of response to faecal microbiota transplantation in patients with ulcerative colitis
    Nia Paddison Rees, Walaa Shaheen, Christopher Quince, Chris Tselepis, Richard D Horniblow, Naveen Sharma, Andrew D Beggs, Tariq H Iqbal, Mohammed Nabil Quraishi
    eBioMedicine.2022; 81: 104088.     CrossRef
  • An updated systematic review and meta-analysis of fecal microbiota transplantation for the treatment of ulcerative colitis
    Taobi Huang, Jinlan Xu, Maoying Wang, Ke Pu, Longquan Li, Huiyun Zhang, Yuan Liang, Weiming Sun, Yuping Wang
    Medicine.2022; 101(30): e29790.     CrossRef
  • Additive effect of probiotics (Mutaflor) on 5-aminosalicylic acid therapy in patients with ulcerative colitis
    Soo-Kyung Park, Sang-Bum Kang, SangSoo Kim, Tae Oh Kim, Jae Myung Cha, Jong Pil Im, Chang Hwan Choi, Eun Soo Kim, Geom Seog Seo, Chang Soo Eun, Dong Soo Han, Dong Il Park
    The Korean Journal of Internal Medicine.2022; 37(5): 949.     CrossRef
  • Early fecal microbiome transfer after donor defecation determines response in patients with moderate to severe ulcerative colitis
    Arshdeep Singh, Ramit Mahajan, Bhavjeet Kaur Kahlon, Ashvin Singh Dhaliwal, Vandana Midha, Varun Mehta, Namita Bansal, Dharmatma Singh, Ajit Sood
    Indian Journal of Gastroenterology.2022; 41(4): 389.     CrossRef
  • Physician education can minimize inappropriate steroid use in patients with inflammatory bowel disease: the ACTION study
    Yehyun Park, Chang Hwan Choi, Hyun Soo Kim, Hee Seok Moon, Do Hyun Kim, Jin Ju Kim, Dennis Teng, Dong Il Park
    Intestinal Research.2022; 20(4): 452.     CrossRef
  • Inflammatory bowel disease in India: challenges and opportunities
    Alice Snell, Jonathan Segal, Jimmy Limdi, Rupa Banerjee
    Frontline Gastroenterology.2021; 12(5): 390.     CrossRef
  • Clinical Predictors of Response to Faecal Microbiota Transplantation in Patients with Active Ulcerative Colitis
    Ajit Sood, Arshdeep Singh, Ramit Mahajan, Vandana Midha, Kirandeep Kaur, Dharmatma Singh, Namita Bansal, Khushdeep Dharni
    Journal of Crohn's and Colitis.2021; 15(2): 238.     CrossRef
  • Long-term efficacy and safety of monotherapy with a single fresh fecal microbiota transplant for recurrent active ulcerative colitis: a prospective randomized pilot study
    Haiming Fang, Lian Fu, Xuejun Li, Chunxia Lu, Yuan Su, Kangwei Xiong, Lijiu Zhang
    Microbial Cell Factories.2021;[Epub]     CrossRef
  • Repeated Fecal Microbial Transplantations and Antibiotic Pre-Treatment Are Linked to Improved Clinical Response and Remission in Inflammatory Bowel Disease: A Systematic Review and Pooled Proportion Meta-Analysis
    Valentin Mocanu, Sabitha Rajaruban, Jerry Dang, Janice Y. Kung, Edward C. Deehan, Karen L. Madsen
    Journal of Clinical Medicine.2021; 10(5): 959.     CrossRef
  • Efficacy and Safety of Fecal Microbiota Transplantation and Prospect of Microbe-based Therapies for Inflammatory Bowel Disease
    Hoon Gil Jo, Geom Seog Seo
    The Korean Journal of Gastroenterology.2021; 78(1): 31.     CrossRef
  • Intestinal microbiota and inflammatory bowel diseases
    Chang Soo Eun
    Journal of the Korean Medical Association.2021; 64(9): 588.     CrossRef
  • The Role of Glucocorticoids in Inflammatory Diseases
    Sybille D. Reichardt, Agathe Amouret, Chiara Muzzi, Sabine Vettorazzi, Jan P. Tuckermann, Fred Lühder, Holger M. Reichardt
    Cells.2021; 10(11): 2921.     CrossRef
  • Acceptability, tolerability, and safety of fecal microbiota transplantation in patients with active ulcerative colitis (AT&S Study)
    Ajit Sood, Arshdeep Singh, Ramit Mahajan, Vandana Midha, Varun Mehta, Yogesh Kumar Gupta, Vikram Narang, Kirandeep Kaur
    Journal of Gastroenterology and Hepatology.2020; 35(3): 418.     CrossRef
  • Washed microbiota transplantation vs. manual fecal microbiota transplantation: clinical findings, animal studies and in vitro screening
    Ting Zhang, Gaochen Lu, Zhe Zhao, Yafei Liu, Quan Shen, Pan Li, Yaoyao Chen, Haoran Yin, Huiquan Wang, Cicilia Marcella, Bota Cui, Lei Cheng, Guozhong Ji, Faming Zhang
    Protein & Cell.2020; 11(4): 251.     CrossRef
  • Efficacy of intestinal microbiota transplantation in ulcerative colitis: a review of current literature and knowledge
    Krista M. Newman, Byron P. Vaughn
    Minerva Gastroenterologica e Dietologica.2020;[Epub]     CrossRef
  • Advances in the understanding of the intestinal micro-environment and inflammatory bowel disease
    Peng-Guang Yan, Jing-Nan Li
    Chinese Medical Journal.2020; 133(7): 834.     CrossRef
  • Gut microbiota in ulcerative colitis: insights on pathogenesis and treatment
    Xiao Yan Guo, Xin Juan Liu, Jian Yu Hao
    Journal of Digestive Diseases.2020; 21(3): 147.     CrossRef
  • Enhancing patient adherence to fecal microbiota transplantation maintains the long-term clinical effects in ulcerative colitis
    Qianqian Li, Ting Zhang, Xiao Ding, Liyuan Xiang, Bota Cui, Heena Buch, Faming Zhang
    European Journal of Gastroenterology & Hepatology.2020; 32(8): 955.     CrossRef
  • Incidental benefits after fecal microbiota transplant for ulcerative colitis
    Ramit Mahajan, Vandana Midha, Arshdeep Singh, Varun Mehta, Yogesh Gupta, Kirandeep Kaur, Ritu Sudhakar, Anmol Singh Pannu, Dharmatma Singh, Ajit Sood
    Intestinal Research.2020; 18(3): 337.     CrossRef
  • Fecal Microbiota Transplantation for Ulcerative Colitis: The Optimum Timing and Gut Microbiota as Predictors for Long-Term Clinical Outcomes
    Qianqian Li, Xiao Ding, Kangjian Liu, Cicilia Marcella, Xiaolin Liu, Ting Zhang, Yafei Liu, Pan Li, Liyuan Xiang, Bota Cui, Jun Wang, Jianling Bai, Faming Zhang
    Clinical and Translational Gastroenterology.2020; 11(8): e00224.     CrossRef
  • Fecal microbiota transplantation in inflammatory bowel disease patients: A systematic review and meta-analysis
    Luciane de Fátima Caldeira, Helena H. Borba, Fernanda S. Tonin, Astrid Wiens, Fernando Fernandez-Llimos, Roberto Pontarolo, Udai P. Singh
    PLOS ONE.2020; 15(9): e0238910.     CrossRef
  • Efficacy and safety of fecal microbiota transplantation by washed preparation in patients with moderate to severely active ulcerative colitis
    Min Chen, Xiao Lei Liu, Yu Jie Zhang, Yong Zhan Nie, Kai Chun Wu, Yong Quan Shi
    Journal of Digestive Diseases.2020; 21(11): 621.     CrossRef
  • Fecal Microbiota Transplantation for Ulcerative Colitis: An Evolving Therapy
    Ajit Sood, Arshdeep Singh, Vandana Midha, Ramit Mahajan, Dina Kao, David T Rubin, Charles N Bernstein
    Crohn's & Colitis 360.2020;[Epub]     CrossRef
  • Efficacy and safety of fecal microbiota transplantation for treating patients with ulcerative colitis: A systematic review and meta‐analysis
    Hai Lan Zhao, Shu Zhen Chen, Hao Ming Xu, You Lian Zhou, Jie He, Hong Li Huang, Jing Xu, Yu Qiang Nie
    Journal of Digestive Diseases.2020; 21(10): 534.     CrossRef
  • Optimising management strategies of inflammatory bowel disease in resource-limited settings in Asia
    Siew C Ng, Joyce Wing Yan Mak, Partha Pal, Rupa Banerjee
    The Lancet Gastroenterology & Hepatology.2020; 5(12): 1089.     CrossRef
  • Lithium Carbonate Treatment Alleviates Gut Inflammation Through Activating Treg Cell Responses in a Microbiota-Dependent Manner
    Shengjie Huang, Bo Tang, Li Tang, Yaojiang Liu, Shuang Liu, Yuanyuan Lei, Shiping Hu, Li Zhong, Shiming Yang, Song He
    SSRN Electronic Journal .2020;[Epub]     CrossRef
  • Fecal Microbiota Transplantation in Intestinal Disorders: A Primer for Physicians
    Ajit Sood, Vandana Midha, Harmeet Kaur, Arshdeep Singh
    Journal of Gastrointestinal Infections.2020; 10(1): 16.     CrossRef
  • Multi-session fecal microbiota transplantation using colonoscopy has favorable outcomes for the treatment of steroid-dependent ulcerative colitis
    Young-Seok Cho
    Intestinal Research.2019; 17(1): 6.     CrossRef
  • Intestinal microbiome as a novel therapeutic target for local and systemic inflammation
    Kazuhiko Uchiyama, Yuji Naito, Tomohisa Takagi
    Pharmacology & Therapeutics.2019; 199: 164.     CrossRef
  • Role of Faecal Microbiota Transplantation for Maintenance of Remission in Patients With Ulcerative Colitis: A Pilot Study
    Ajit Sood, Ramit Mahajan, Arshdeep Singh, Vandana Midha, Varun Mehta, Vikram Narang, Tarundeep Singh, Anmol Singh Pannu
    Journal of Crohn's and Colitis.2019; 13(10): 1311.     CrossRef
  • Evolution of fecal microbiota transplantation in methodology and ethical issues
    Faming Zhang, Ting Zhang, Heming Zhu, Thomas J Borody
    Current Opinion in Pharmacology.2019; 49: 11.     CrossRef
  • 9,616 View
  • 276 Download
  • 42 Web of Science
  • 40 Crossref
Close layer

Intest Res : Intestinal Research
Close layer
TOP